[HTML][HTML] The benefits of sacubitril-valsartan in low ejection fraction heart failure

L Aşkın, O Tanrıverdi - Abant Medical Journal, 2022 - dergipark.org.tr
Heart failure (HF) is the cause of impaired exercise capacity due to insufficient peripheral
blood flow. The development of natriuretic peptide (NP) through inhibition of the neprilysin …

[HTML][HTML] Long-term cardiac effect of sacubitril-valsartan in hemodialysis patients with a reduced ejection fraction after aortic valve replacement for aortic stenosis: a …

S Daimon, Y Sakamoto, M Yasuda… - Renal Replacement …, 2023 - Springer
Background Although the angiotensin receptor-neprilysin inhibitor sacubitril-valsartan has
demonstrated a valuable effect on cardiac function in patients with heart failure with a …

Functional changes in the heart after sacubitril/valsartan use in 5 hemodialysis patients with hypertension. Case report

N Kuwae - CEN case reports, 2023 - Springer
The purpose of this report is to describe the efficacy of sacubitril/valsartan in 5 hemodialysis
patients with hypertension, including a patient with heart failure with reduced ejection …

Drug-Induced Acute Dystonia After Sacubitril/Valsartan Combination

P Tewari, S Pande, D Arora - Annals of Internal Medicine: Clinical …, 2024 - acpjournals.org
Adverse drug reaction by definition can be an unpleasant response due to a drug use that
can adversely affect a person and may call for either treatment or withdrawal of the …

[PDF][PDF] Abant Tıp Dergisi

L AŞKIN, O TANRIVERDİ - Heart Failure, 2020 - researchgate.net
Öz Kalp yetmezliği (KY), perifere yetersiz kan akışı nedeniyle egzersiz kapasitesinin
bozulmasının nedenidir. Neprilisin enziminin inhibisyonu yoluyla natriüretik peptit (NP) …